MEDINDIA
English
हिन्दी
Español
français
中文
Email
4-Phenylbutyric Acid
The serum concentration of Metoprolol can be increased when it is combined with Phenylbutyric acid.
Abiraterone
The serum concentration of Metoprolol can be increased when it is combined with Abiraterone.
Acebutolol
The serum concentration of Metoprolol can be increased when it is combined with Acebutolol.
Aceclofenac
Aceclofenac may decrease the antihypertensive activities of Metoprolol.
Acemetacin
The therapeutic efficacy of Metoprolol can be decreased when used in combination with Acemetacin.
Acepromazine
Metoprolol may increase the orthostatic hypotensive activities of Acepromazine.
Aceprometazine
Aceprometazine may increase the hypotensive activities of Metoprolol.
Acetaminophen
The metabolism of Acetaminophen can be decreased when combined with Metoprolol.
Acetohexamide
Metoprolol may increase the hypoglycemic activities of Acetohexamide.
Acetyl salicylate
Acetylsalicylic acid may decrease the antihypertensive activities of Metoprolol.
Acetylcholine
The metabolism of Acetylcholine can be decreased when combined with Metoprolol.
Acetylcholine Chloride
The metabolism of Acetylcholine can be decreased when combined with Metoprolol.
Acetyldigitoxin
Metoprolol may increase the bradycardic activities of Acetyldigitoxin.
Adapalene
Adapalene may decrease the antihypertensive activities of Metoprolol.
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Metoprolol.
Ajmaline
The serum concentration of Metoprolol can be increased when it is combined with Ajmaline.
Albuterol
Metoprolol may decrease the bronchodilatory activities of Salbutamol.
Aldesleukin
The risk or severity of adverse effects can be increased when Aldesleukin is combined with Metoprolol.
Alfentanil
Alfentanil may increase the bradycardic activities of Metoprolol.
Alfuzosin
Alfuzosin may increase the hypotensive activities of Metoprolol.
Aliskiren
Metoprolol may increase the hypotensive activities of Aliskiren.
Alminoprofen
Alminoprofen may decrease the antihypertensive activities of Metoprolol.
Almotriptan
The metabolism of Almotriptan can be decreased when combined with Metoprolol.
Alogliptin
The metabolism of Alogliptin can be decreased when combined with Metoprolol.
Alprenolol
The metabolism of Alprenolol can be decreased when combined with Metoprolol.
Ambenonium
Ambenonium may increase the bradycardic activities of Metoprolol.
Ambrisentan
Metoprolol may increase the hypotensive activities of Ambrisentan.
AMBROXOL ACEFYLLINATE
Metoprolol may decrease the bronchodilatory activities of Ambroxol acefyllinate.
Ambroxol-Theophylline-7-Acetate
Metoprolol may decrease the bronchodilatory activities of Ambroxol acefyllinate.
Amifostine
Metoprolol may increase the hypotensive activities of Amifostine.
Amifostine Anhydrous
Metoprolol may increase the hypotensive activities of Amifostine.
Amiloride
The risk or severity of adverse effects can be increased when Metoprolol is combined with Amiloride.
Aminophylline
Metoprolol may decrease the bronchodilatory activities of Aminophylline.
Aminopyrine
The metabolism of Aminophenazone can be decreased when combined with Metoprolol.
Amiodarone
The serum concentration of Metoprolol can be increased when it is combined with Amiodarone.
Amitriptyline
The serum concentration of Metoprolol can be increased when it is combined with Amitriptyline.
Amlodipine
The serum concentration of Metoprolol can be increased when it is combined with Amlodipine.
Amobarbital
The serum concentration of Metoprolol can be decreased when it is combined with Amobarbital.
Amodiaquine
The serum concentration of Metoprolol can be increased when it is combined with Amodiaquine.
Amoxapine
Metoprolol may increase the orthostatic hypotensive activities of Amoxapine.
Amphetamine
The serum concentration of Metoprolol can be increased when it is combined with Amphetamine.
Amphotericin B
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Metoprolol.
amphotericin B liposomal
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Metoprolol.
Amprenavir
The metabolism of Amprenavir can be decreased when combined with Metoprolol.
Amsacrine
The metabolism of Amsacrine can be decreased when combined with Metoprolol.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Metoprolol is combined with Amyl Nitrite.
Antipyrine
The serum concentration of Metoprolol can be increased when it is combined with Antipyrine.
Apalutamide
The serum concentration of Metoprolol can be decreased when it is combined with Apalutamide.
Apazone
Azapropazone may decrease the antihypertensive activities of Metoprolol.
Apomorphine
Apomorphine may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Apraclonidine
The risk or severity of adverse effects can be increased when Metoprolol is combined with Apraclonidine.
Apremilast
Apremilast may decrease the antihypertensive activities of Metoprolol.
Aprindine
The metabolism of Aprindine can be decreased when combined with Metoprolol.
Arbutamine
Metoprolol may decrease the bronchodilatory activities of Arbutamine.
Arformoterol
The metabolism of Arformoterol can be decreased when combined with Metoprolol.
Aripiprazole
The serum concentration of Metoprolol can be increased when it is combined with Aripiprazole.
Armodafinil
The metabolism of Metoprolol can be decreased when combined with Armodafinil.
Arsenic Trioxide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Metoprolol.
Artemether
The serum concentration of Metoprolol can be increased when it is combined with Artemether.
Asenapine
The serum concentration of Metoprolol can be increased when it is combined with Asenapine.
Aspirin
Acetylsalicylic acid may decrease the antihypertensive activities of Metoprolol.
Astemizole
The metabolism of Astemizole can be decreased when combined with Metoprolol.
Asunaprevir
The metabolism of Asunaprevir can be decreased when combined with Metoprolol.
Atenolol
Metoprolol may increase the hypotensive activities of Atenolol.
Atomoxetine
The serum concentration of Metoprolol can be increased when it is combined with Atomoxetine.
Atorvastatin
The serum concentration of Metoprolol can be increased when it is combined with Atorvastatin.
Avanafil
Avanafil may increase the antihypertensive activities of Metoprolol.
Azelastine
The serum concentration of Metoprolol can be increased when it is combined with Azelastine.
Azilsartan
The risk or severity of adverse effects can be increased when Metoprolol is combined with Azilsartan medoxomil.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Metoprolol is combined with Azilsartan medoxomil.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Metoprolol is combined with Azilsartan medoxomil.
Balsalazide
Balsalazide may decrease the antihypertensive activities of Metoprolol.
Bambuterol
Metoprolol may decrease the bronchodilatory activities of Bambuterol.
Barbexaclone
The serum concentration of Metoprolol can be decreased when it is combined with Barbexaclone.
Barbital
The serum concentration of Metoprolol can be decreased when it is combined with Barbital.
Benazepril
Metoprolol may increase the hypotensive activities of Benazepril.
Bendroflumethiazide
Metoprolol may increase the hypotensive activities of Bendroflumethiazide.
Benzphetamine
Benzphetamine may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Benztropine
The metabolism of Benzatropine can be decreased when combined with Metoprolol.
Benzydamine
Benzydamine may decrease the antihypertensive activities of Metoprolol.
Benzyl Alcohol
The metabolism of Benzyl alcohol can be decreased when combined with Metoprolol.
Bepridil
The metabolism of Bepridil can be decreased when combined with Metoprolol.
Beractant
Metoprolol may increase the bradycardic activities of Beractant.
Betaxolol
The serum concentration of Metoprolol can be increased when it is combined with Betaxolol.
Bethanechol
The risk or severity of adverse effects can be increased when Metoprolol is combined with Bethanechol.
Bethanidine
Bethanidine may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Bicalutamide
The serum concentration of Metoprolol can be increased when it is combined with Bicalutamide.
Bimatoprost
Metoprolol may increase the hypotensive activities of Bimatoprost.
Biperiden
The serum concentration of Metoprolol can be increased when it is combined with Biperiden.
Bisoprolol
The metabolism of Bisoprolol can be decreased when combined with Metoprolol.
Bitolterol
Metoprolol may decrease the bronchodilatory activities of Bitolterol.
Bitolterol Mesylate
Metoprolol may decrease the bronchodilatory activities of Bitolterol.
Black Cohosh Extract
The serum concentration of Metoprolol can be increased when it is combined with Cimicifuga racemosa.
Bortezomib
The serum concentration of Metoprolol can be increased when it is combined with Bortezomib.
Bosentan
Bosentan may increase the hypotensive activities of Metoprolol.
Bosentan Anhydrous
Bosentan may increase the hypotensive activities of Metoprolol.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Metoprolol.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Metoprolol.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Metoprolol.
Bretylium
Bretylium may increase the bradycardic activities of Metoprolol.
Brexpiprazole
The serum concentration of Brexpiprazole can be increased when it is combined with Metoprolol.
Brimonidine
Brimonidine may increase the antihypertensive activities of Metoprolol.
Bromfenac
Bromfenac may decrease the antihypertensive activities of Metoprolol.
Bromocriptine
Bromocriptine may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Brompheniramine
The serum concentration of Metoprolol can be increased when it is combined with Brompheniramine.
Bufexamac
Bufexamac may decrease the antihypertensive activities of Metoprolol.
Bumetanide
The risk or severity of adverse effects can be increased when Metoprolol is combined with Bumetanide.
Bunazosin
Metoprolol may increase the orthostatic hypotensive activities of Bunazosin.
Bupivacaine
The serum concentration of Bupivacaine can be increased when it is combined with Metoprolol.
Bupranolol
Metoprolol may increase the hypotensive activities of Bupranolol.
Buprenorphine
The serum concentration of Metoprolol can be increased when it is combined with Buprenorphine.
Bupropion
The serum concentration of Metoprolol can be increased when it is combined with Bupropion.
Buspirone
The metabolism of Buspirone can be decreased when combined with Metoprolol.
Cabergoline
Metoprolol may increase the vasoconstricting activities of Cabergoline.
Cafedrine
Metoprolol may increase the hypotensive activities of Cafedrine.
Caffeine
The metabolism of Caffeine can be decreased when combined with Metoprolol.
Calfactant
Metoprolol may increase the bradycardic activities of Calfactant.
Canagliflozin
The risk or severity of adverse effects can be increased when Metoprolol is combined with Canagliflozin.
Canagliflozin Anhydrous
The risk or severity of adverse effects can be increased when Metoprolol is combined with Canagliflozin.
Candesartan
Metoprolol may increase the hypotensive activities of Candesartan.
Candesartan Cilexetil
Metoprolol may increase the hypotensive activities of Candesartan cilexetil.
Captopril
The metabolism of Captopril can be decreased when combined with Metoprolol.
Carbachol
The risk or severity of adverse effects can be increased when Metoprolol is combined with Carbachol.
Carbamazepine
The metabolism of Metoprolol can be increased when combined with Carbamazepine.
Carbinoxamine
The serum concentration of Metoprolol can be increased when it is combined with Carbinoxamine.
Cariprazine
The metabolism of Cariprazine can be decreased when combined with Metoprolol.
Carprofen
Carprofen may decrease the antihypertensive activities of Metoprolol.
Carteolol
The serum concentration of Metoprolol can be increased when it is combined with Carteolol.
Carvedilol
Metoprolol may increase the orthostatic hypotensive activities of Carvedilol.
Celecoxib
The serum concentration of Metoprolol can be increased when it is combined with Celecoxib.
Celiprolol
Metoprolol may increase the hypotensive activities of Celiprolol.
Cephalexin
The metabolism of Cephalexin can be decreased when combined with Metoprolol.
CEPHALEXIN ANHYDROUS
The metabolism of Cephalexin can be decreased when combined with Metoprolol.
Ceritinib
Metoprolol may increase the bradycardic activities of Ceritinib.
Cerivastatin
The serum concentration of Metoprolol can be increased when it is combined with Cerivastatin.
Cevimeline
The metabolism of Cevimeline can be decreased when combined with Metoprolol.
Chloramphenicol
The metabolism of Metoprolol can be decreased when combined with Chloramphenicol.
Chlordiazepoxide
The metabolism of Chlordiazepoxide can be decreased when combined with Metoprolol.
Chloroquine
The serum concentration of Metoprolol can be increased when it is combined with Chloroquine.
Chlorothiazide
Metoprolol may increase the hypotensive activities of Chlorothiazide.
Chlorpheniramine
The serum concentration of Metoprolol can be increased when it is combined with Chlorphenamine.
CHLORPHENIRAMINE POLISTIREX
The serum concentration of Metoprolol can be increased when it is combined with Chlorphenamine.
Chlorpromazine
The serum concentration of Metoprolol can be increased when it is combined with Chlorpromazine.
Chlorpropamide
Metoprolol may increase the hypoglycemic activities of Chlorpropamide.
Chlorthalidone
Metoprolol may increase the hypotensive activities of Chlorthalidone.
Chlorzoxazone
The metabolism of Chlorzoxazone can be decreased when combined with Metoprolol.
Cholecalciferol
The serum concentration of Metoprolol can be increased when it is combined with Cholecalciferol.
Choline Magnesium Trisalicyclate
Choline magnesium trisalicylate may decrease the antihypertensive activities of Metoprolol.
Cicletanine
Metoprolol may increase the hypotensive activities of Cicletanine.
Cilazapril
Metoprolol may increase the hypotensive activities of Cilazapril.
Cilostazol
The metabolism of Cilostazol can be decreased when combined with Metoprolol.
Cimetidine
The serum concentration of Metoprolol can be increased when it is combined with Cimetidine.
Cinacalcet
The serum concentration of Metoprolol can be increased when it is combined with Cinacalcet.
Cinnarizine
The metabolism of Cinnarizine can be decreased when combined with Metoprolol.
Cisapride
The serum concentration of Metoprolol can be increased when it is combined with Cisapride.
Citalopram
The serum concentration of Metoprolol can be increased when it is combined with Citalopram.
Clemastine
The serum concentration of Metoprolol can be increased when it is combined with Clemastine.
Clenbuterol
Metoprolol may decrease the bronchodilatory activities of Clenbuterol.
Clevidipine
The metabolism of Clevidipine can be decreased when combined with Metoprolol.
Clevidipine butyrate
The metabolism of Clevidipine can be decreased when combined with Metoprolol.
Clobazam
The serum concentration of Metoprolol can be increased when it is combined with Clobazam.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Metoprolol.
Clofezone
The serum concentration of Metoprolol can be increased when it is combined with Rabeprazole.
Clomipramine
The serum concentration of Metoprolol can be increased when it is combined with Clomipramine.
Clonidine
Clonidine may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Clonixin
Clonixin may decrease the antihypertensive activities of Metoprolol.
Clotrimazole
The serum concentration of Metoprolol can be increased when it is combined with Clotrimazole.
Clozapine
The serum concentration of Metoprolol can be increased when it is combined with Clozapine.
Cobicistat
The serum concentration of Metoprolol can be increased when it is combined with Cobicistat.
Cocaine
The serum concentration of Metoprolol can be increased when it is combined with Cocaine.
Codeine
The serum concentration of Metoprolol can be increased when it is combined with Codeine.
Codeine Anhydrous
The serum concentration of Metoprolol can be increased when it is combined with Codeine.
CODEINE POLISTIREX
The serum concentration of Metoprolol can be increased when it is combined with Codeine.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Metoprolol.
Conivaptan
The risk or severity of adverse effects can be increased when Conivaptan is combined with Metoprolol.
Crizotinib
Metoprolol may increase the bradycardic activities of Crizotinib.
Cryptenamine
Metoprolol may increase the hypotensive activities of Cryptenamine.
Curcumin
The serum concentration of Metoprolol can be increased when it is combined with Curcumin.
Cyclobenzaprine
The metabolism of Cyclobenzaprine can be decreased when combined with Metoprolol.
Cyclopenthiazide
Metoprolol may increase the hypotensive activities of Cyclopenthiazide.
Cyclophosphamide
The metabolism of Cyclophosphamide can be decreased when combined with Metoprolol.
Cyclophosphamide Anhydrous
The metabolism of Cyclophosphamide can be decreased when combined with Metoprolol.
Cyclosporine
The serum concentration of Metoprolol can be increased when it is combined with Cyclosporine.
Cyclothiazide
Metoprolol may increase the hypotensive activities of Cyclothiazide.
Cyproterone Acetate
The serum concentration of Metoprolol can be increased when it is combined with Cyproterone acetate.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Metoprolol.
Dabrafenib
The serum concentration of Metoprolol can be decreased when it is combined with Dabrafenib.
Dapagliflozin
The metabolism of Dapagliflozin can be decreased when combined with Metoprolol.
Dapiprazole
Metoprolol may increase the orthostatic hypotensive activities of Dapiprazole.
Darifenacin
The serum concentration of Metoprolol can be increased when it is combined with Darifenacin.
Darunavir
The serum concentration of Metoprolol can be increased when it is combined with Darunavir.
Dasabuvir
The metabolism of Dasabuvir can be decreased when combined with Metoprolol.
Debrisoquin
The metabolism of Debrisoquin can be decreased when combined with Metoprolol.
Delavirdine
The serum concentration of Metoprolol can be increased when it is combined with Delavirdine.
Demecarium
Demecarium may increase the bradycardic activities of Metoprolol.
Deserpidine
Metoprolol may increase the hypotensive activities of Deserpidine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Metoprolol.
Desipramine
The serum concentration of Metoprolol can be increased when it is combined with Desipramine.
Deslanoside
Metoprolol may increase the bradycardic activities of Deslanoside.
Desloratadine
The serum concentration of Metoprolol can be increased when it is combined with Desloratadine.
Desvenlafaxine
The serum concentration of Metoprolol can be increased when it is combined with Desvenlafaxine.
Deutetrabenazine
The metabolism of Deutetrabenazine can be decreased when combined with Metoprolol.
Dexchlorpheniramine maleate
The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Metoprolol.
Dexfenfluramine
The serum concentration of Metoprolol can be increased when it is combined with Dexfenfluramine.
Dexmedetomidine
The serum concentration of Metoprolol can be increased when it is combined with Dexmedetomidine.
Dexmethylphenidate
The serum concentration of Metoprolol can be increased when it is combined with Dexmethylphenidate.
Dextroamphetamine
The serum concentration of Metoprolol can be increased when it is combined with Dextroamphetamine.
Dextromethorphan
The serum concentration of Metoprolol can be increased when it is combined with Dextromethorphan.
Diacetylrhein
The serum concentration of Metoprolol can be increased when it is combined with Diacerein.
Diazoxide
Diazoxide may increase the hypotensive activities of Metoprolol.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Metoprolol is combined with Diclofenamide.
Diclofenac
Diclofenac may decrease the antihypertensive activities of Metoprolol.
Diflunisal
Diflunisal may decrease the antihypertensive activities of Metoprolol.
Digitoxin
Metoprolol may increase the bradycardic activities of Digitoxin.
Digoxin
Metoprolol may increase the bradycardic activities of Digoxin.
Dihydralazine
Dihydralazine may increase the hypotensive activities of Metoprolol.
Dihydrocodeine
The metabolism of Dihydrocodeine can be decreased when combined with Metoprolol.
Dihydroergotamine
Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Diltiazem
The serum concentration of Metoprolol can be increased when it is combined with Diltiazem.
Dimethyl Sulfoxide
The serum concentration of Metoprolol can be increased when it is combined with Dimethyl sulfoxide.
Dinutuximab
The risk or severity of adverse effects can be increased when Metoprolol is combined with Dinutuximab.
Diphenhydramine
The serum concentration of Metoprolol can be increased when it is combined with Diphenhydramine.
Dipivefrin
Dipivefrin may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Dipyridamole
Dipyridamole may increase the bradycardic activities of Metoprolol.
Dipyrone
Metamizole may decrease the antihypertensive activities of Metoprolol.
Disopyramide
Disopyramide may increase the bradycardic activities of Metoprolol.
Distigmine
Distigmine may increase the bradycardic activities of Metoprolol.
Disulfiram
The serum concentration of Metoprolol can be increased when it is combined with Disulfiram.
Dobutamine
Metoprolol may decrease the bronchodilatory activities of Dobutamine.
Dolasetron
The serum concentration of Metoprolol can be increased when it is combined with Dolasetron.
Domperidone
The metabolism of Domperidone can be decreased when combined with Metoprolol.
Donepezil
Donepezil may increase the bradycardic activities of Metoprolol.
Dopamine
The metabolism of Dopamine can be decreased when combined with Metoprolol.
Dorzolamide
Metoprolol may increase the hypotensive activities of Dorzolamide.
Dothiepin
The serum concentration of Metoprolol can be increased when it is combined with Dosulepin.
Doxazosin
Metoprolol may increase the orthostatic hypotensive activities of Doxazosin.
Doxepin
The serum concentration of Metoprolol can be increased when it is combined with Doxepin.
Doxorubicin
The serum concentration of Metoprolol can be increased when it is combined with Doxorubicin.
Doxorubicin Hydrochloride
The serum concentration of Metoprolol can be increased when it is combined with Doxorubicin.
Dronedarone
The serum concentration of Metoprolol can be increased when it is combined with Dronedarone.
Droperidol
Metoprolol may increase the orthostatic hypotensive activities of Droperidol.
Droxicam
Droxicam may decrease the antihypertensive activities of Metoprolol.
Droxidopa
Droxidopa may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Duloxetine
The serum concentration of Metoprolol can be increased when it is combined with Duloxetine.
Dyphylline
Metoprolol may decrease the bronchodilatory activities of Dyphylline.
Echothiophate
Echothiophate may increase the bradycardic activities of Metoprolol.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Metoprolol.
Edrophonium
Edrophonium may increase the bradycardic activities of Metoprolol.
Efavirenz
The serum concentration of Metoprolol can be increased when it is combined with Efavirenz.
Eletriptan
The metabolism of Eletriptan can be decreased when combined with Metoprolol.
Eliglustat
The serum concentration of Eliglustat can be increased when it is combined with Metoprolol.
Empagliflozin
The risk or severity of adverse effects can be increased when Metoprolol is combined with Empagliflozin.
Enalapril
Metoprolol may increase the hypotensive activities of Enalapril.
Enalaprilat
Metoprolol may increase the hypotensive activities of Enalaprilat.
Enalaprilat Anhydrous
Metoprolol may increase the hypotensive activities of Enalaprilat.
Enasidenib
The serum concentration of Metoprolol can be increased when it is combined with Enasidenib.
Encainide
The metabolism of Encainide can be decreased when combined with Metoprolol.
Entacapone
The serum concentration of Metoprolol can be increased when it is combined with Entacapone.
Enzalutamide
The serum concentration of Metoprolol can be increased when it is combined with Enzalutamide.
Epinastine
The serum concentration of Metoprolol can be increased when it is combined with Epinastine.
Epinephrine
Epinephrine may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Eplerenone
The risk or severity of adverse effects can be increased when Metoprolol is combined with Eplerenone.
Epoprostenol
Metoprolol may increase the hypotensive activities of Epoprostenol.
Eprosartan
Metoprolol may increase the hypotensive activities of Eprosartan.
ergoloid mesylates, USP
Metoprolol may increase the vasoconstricting activities of Ergoloid mesylate.
Ergonovine
Metoprolol may increase the vasoconstricting activities of Ergonovine.
Ergotamine
Ergotamine may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Erlotinib
The metabolism of Erlotinib can be decreased when combined with Metoprolol.
Escitalopram
The serum concentration of Metoprolol can be increased when it is combined with Escitalopram.
Eslicarbazepine Acetate
The metabolism of Metoprolol can be decreased when combined with Eslicarbazepine acetate.
Esmolol
The risk or severity of adverse effects can be increased when Esmolol is combined with Metoprolol.
Esomeprazole
The metabolism of Metoprolol can be decreased when combined with Esomeprazole.
Etanercept
Etanercept may decrease the antihypertensive activities of Metoprolol.
Ethacrynate
The risk or severity of adverse effects can be increased when Metoprolol is combined with Etacrynic acid.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Metoprolol is combined with Etacrynic acid.
Ethylmorphine
The metabolism of Ethylmorphine can be decreased when combined with Metoprolol.
Etodolac
Etodolac may decrease the antihypertensive activities of Metoprolol.
Etofenamate
Etofenamate may decrease the antihypertensive activities of Metoprolol.
Etomidate
Etomidate may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Etoricoxib
The serum concentration of Metoprolol can be increased when it is combined with Etoricoxib.
Etravirine
The metabolism of Metoprolol can be decreased when combined with Etravirine.
Evening primrose oil
Evening primrose oil may decrease the antihypertensive activities of Metoprolol.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Metoprolol.
Felbinac
Felbinac may decrease the antihypertensive activities of Metoprolol.
Felodipine
The serum concentration of Metoprolol can be increased when it is combined with Felodipine.
Fenbufen
Fenbufen may decrease the antihypertensive activities of Metoprolol.
Fenfluramine
The serum concentration of Metoprolol can be increased when it is combined with Fenfluramine.
Fenoldopam
Metoprolol may increase the hypotensive activities of Fenoldopam.
Fenoprofen
Fenoprofen may decrease the antihypertensive activities of Metoprolol.
Fenoterol
Metoprolol may decrease the bronchodilatory activities of Fenoterol.
Fentanyl
Fentanyl may increase the bradycardic activities of Metoprolol.
Ferulic Acid
Metoprolol may increase the hypotensive activities of Ferulic acid.
Fesoterodine
The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Metoprolol.
Fexofenadine
The serum concentration of Metoprolol can be increased when it is combined with Fexofenadine.
Fingolimod
Metoprolol may increase the bradycardic activities of Fingolimod.
Flecainide
The serum concentration of Metoprolol can be increased when it is combined with Flecainide.
Floctafenine
The risk or severity of adverse effects can be increased when Metoprolol is combined with Floctafenine.
Fluconazole
The metabolism of Metoprolol can be decreased when combined with Fluconazole.
Flunarizine
The metabolism of Flunarizine can be decreased when combined with Metoprolol.
Fluoxetine
The serum concentration of Metoprolol can be increased when it is combined with Fluoxetine.
Flupenthixol
Metoprolol may increase the orthostatic hypotensive activities of Flupentixol.
Fluphenazine
The serum concentration of Metoprolol can be increased when it is combined with Fluphenazine.
Flurbiprofen
Flurbiprofen may decrease the antihypertensive activities of Metoprolol.
Fluvastatin
The serum concentration of Metoprolol can be increased when it is combined with Fluvastatin.
Fluvoxamine
The serum concentration of Metoprolol can be increased when it is combined with Fluvoxamine.
Formoterol
The metabolism of Formoterol can be decreased when combined with Metoprolol.
Fosinopril
Metoprolol may increase the hypotensive activities of Fosinopril.
Fosphenytoin
The metabolism of Metoprolol can be increased when combined with Fosphenytoin.
Fostamatinib
Fostamatinib may increase the antihypertensive activities of Metoprolol.
Furazolidone
Furazolidone may increase the hypotensive activities of Metoprolol.
Furosemide
The risk or severity of adverse effects can be increased when Metoprolol is combined with Furosemide.
Galantamine
Galantamine may increase the bradycardic activities of Metoprolol.
Gallamine Triethiodide
Gallamine Triethiodide may increase the bradycardic activities of Metoprolol.
Gefitinib
The serum concentration of Metoprolol can be increased when it is combined with Gefitinib.
Gemfibrozil
The metabolism of Metoprolol can be decreased when combined with Gemfibrozil.
Ginkgo biloba extract
Ginkgo biloba may increase the bradycardic activities of Metoprolol.
Glibornuride
Metoprolol may increase the hypoglycemic activities of Glibornuride.
Gliclazide
Metoprolol may increase the hypoglycemic activities of Gliclazide.
Glimepiride
Metoprolol may increase the hypoglycemic activities of Glimepiride.
Glipizide
Metoprolol may increase the hypoglycemic activities of Glipizide.
Gliquidone
Metoprolol may increase the hypoglycemic activities of Gliquidone.
Glyburide
Metoprolol may increase the hypoglycemic activities of Glyburide.
Glycerol Phenylbutyrate
The serum concentration of Metoprolol can be increased when it is combined with Glycerol Phenylbutyrate.
Granisetron
The serum concentration of Metoprolol can be increased when it is combined with Granisetron.
Guanabenz
Guanabenz may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Guanadrel
Guanadrel may increase the hypotensive activities of Metoprolol.
Guanethidine
Metoprolol may increase the hypotensive activities of Guanethidine.
Guanfacine
Guanfacine may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Halofantrine
The serum concentration of Metoprolol can be increased when it is combined with Halofantrine.
Haloperidol
The serum concentration of Metoprolol can be increased when it is combined with Haloperidol.
Halothane
The metabolism of Halothane can be decreased when combined with Metoprolol.
Hexobarbital
The serum concentration of Metoprolol can be decreased when it is combined with Hexobarbital.
Hexoprenaline
Metoprolol may decrease the bronchodilatory activities of Hexoprenaline.
Histamine
The serum concentration of Metoprolol can be increased when it is combined with Histamine.
Hydralazine
Hydralazine may increase the hypotensive activities of Metoprolol.
Hydrochlorothiazide
Metoprolol may increase the hypotensive activities of Hydrochlorothiazide.
Hydrocodone
The metabolism of Hydrocodone can be decreased when combined with Metoprolol.
HYDROCODONE POLISTIREX
The metabolism of Hydrocodone can be decreased when combined with Metoprolol.
Hydroflumethiazide
Metoprolol may increase the hypotensive activities of Hydroflumethiazide.
Hydromorphone
The metabolism of Hydromorphone can be decreased when combined with Metoprolol.
Hydroxychloroquine
The serum concentration of Metoprolol can be increased when it is combined with Hydroxychloroquine.
Hydroxyurea
The serum concentration of Metoprolol can be increased when it is combined with Hydroxyurea.
Hydroxyzine
The serum concentration of Metoprolol can be increased when it is combined with Hydroxyzine.
Ibrutinib
The metabolism of Ibrutinib can be decreased when combined with Metoprolol.
Ibuprofen
Ibuprofen may decrease the antihypertensive activities of Metoprolol.
Icatibant
Icatibant may decrease the antihypertensive activities of Metoprolol.
Idarubicin
The serum concentration of Metoprolol can be increased when it is combined with Idarubicin.
Iloperidone
Metoprolol may increase the orthostatic hypotensive activities of Iloperidone.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Metoprolol.
Imatinib
The serum concentration of Metoprolol can be increased when it is combined with Imatinib.
Imidapril
Metoprolol may increase the hypotensive activities of Imidapril.
Imipramine
The serum concentration of Metoprolol can be increased when it is combined with Imipramine.
Indacaterol
Metoprolol may decrease the bronchodilatory activities of Indacaterol.
Indapamide
Metoprolol may increase the hypotensive activities of Indapamide.
Indinavir
The serum concentration of Metoprolol can be increased when it is combined with Indinavir.
INDINAVIR ANHYDROUS
The serum concentration of Metoprolol can be increased when it is combined with Indinavir.
Indobufen
Indobufen may decrease the antihypertensive activities of Metoprolol.
Indomethacin
Indomethacin may decrease the antihypertensive activities of Metoprolol.
Indoramin
Metoprolol may increase the orthostatic hypotensive activities of Indoramin.
insulin human, rDNA origin
Metoprolol may increase the hypoglycemic activities of Insulin Human.
Insulin, Pork
Metoprolol may increase the hypoglycemic activities of Insulin Pork.
Insulin, Regular, Pork
Metoprolol may increase the hypoglycemic activities of Insulin Pork.
Ipecac
The metabolism of Ipecac can be decreased when combined with Metoprolol.
Ipratropium
The metabolism of Ipratropium bromide can be decreased when combined with Metoprolol.
Ipratropium cation
The metabolism of Ipratropium bromide can be decreased when combined with Metoprolol.
Iproniazid
Iproniazid may increase the hypotensive activities of Metoprolol.
Irbesartan
The serum concentration of Metoprolol can be increased when it is combined with Irbesartan.
Isavuconazole
The serum concentration of Metoprolol can be increased when it is combined with Isavuconazole.
Isocarboxazid
Isocarboxazid may increase the hypotensive activities of Metoprolol.
Isoetharine
Metoprolol may decrease the bronchodilatory activities of Isoetarine.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Metoprolol.
Isoflurophate
Isoflurophate may increase the bradycardic activities of Metoprolol.
Isoniazid
The serum concentration of Metoprolol can be increased when it is combined with Isoniazid.
Isoproterenol
Metoprolol may decrease the bronchodilatory activities of Isoprenaline.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Metoprolol is combined with Isosorbide Dinitrate.
Isosorbide Mononitrate
The risk or severity of adverse effects can be increased when Metoprolol is combined with Isosorbide Mononitrate.
Isoxsuprine
The risk or severity of adverse effects can be increased when Metoprolol is combined with Isoxsuprine.
Isradipine
Metoprolol may increase the hypotensive activities of Isradipine.
Itraconazole
The serum concentration of Metoprolol can be increased when it is combined with Itraconazole.
Ivabradine
Metoprolol may increase the bradycardic activities of Ivabradine.
Ixazomib
The metabolism of Ixazomib can be decreased when combined with Metoprolol.
Kebuzone
Kebuzone may decrease the antihypertensive activities of Metoprolol.
Ketanserin
Ketanserin may increase the hypotensive activities of Metoprolol.
Ketoconazole
The serum concentration of Metoprolol can be increased when it is combined with Ketoconazole.
Ketoprofen
Ketoprofen may decrease the antihypertensive activities of Metoprolol.
Ketorolac
Ketorolac may decrease the antihypertensive activities of Metoprolol.
Labetalol
The serum concentration of Metoprolol can be increased when it is combined with Labetalol.
Lacidipine
Metoprolol may increase the hypotensive activities of Lacidipine.
Lacosamide
Metoprolol may increase the atrioventricular blocking (AV block) activities of Lacosamide.
Lanreotide
Metoprolol may increase the bradycardic activities of Lanreotide.
Lansoprazole
The serum concentration of Metoprolol can be increased when it is combined with Lansoprazole.
Latanoprost
Metoprolol may increase the hypotensive activities of Latanoprost.
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Metoprolol.
Leflunomide
Leflunomide may decrease the antihypertensive activities of Metoprolol.
Lercanidipine
The serum concentration of Lercanidipine can be decreased when it is combined with Metoprolol.
Letermovir
The metabolism of Letermovir can be decreased when combined with Metoprolol.
Levalbuterol
The serum concentration of Metoprolol can be increased when it is combined with Levosalbutamol.
Levobunolol
The risk or severity of adverse effects can be increased when Metoprolol is combined with Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Metoprolol.
Levodopa
Metoprolol may increase the orthostatic hypotensive activities of Levodopa.
Levomilnacipran
The metabolism of Levomilnacipran can be decreased when combined with Metoprolol.
Levonordefrin
Levonordefrin may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Levosimendan
The risk or severity of adverse effects can be increased when Levosimendan is combined with Metoprolol.
Lidocaine
The serum concentration of Metoprolol can be increased when it is combined with Lidocaine.
Limonene, (+)-
(4R)-limonene may decrease the antihypertensive activities of Metoprolol.
Lisdexamfetamine
Metoprolol may increase the orthostatic hypotensive activities of Lisdexamfetamine.
Lisdexamfetamine Dimesylate
Metoprolol may increase the orthostatic hypotensive activities of Lisdexamfetamine.
Lisinopril
Metoprolol may increase the hypotensive activities of Lisinopril.
Lisinopril Anhydrous
Metoprolol may increase the hypotensive activities of Lisinopril.
Lisuride
The metabolism of Lisuride can be decreased when combined with Metoprolol.
Lobeline
The risk or severity of adverse effects can be increased when Metoprolol is combined with Lobeline.
Lofexidine
Lofexidine may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Lomustine
The serum concentration of Metoprolol can be increased when it is combined with Lomustine.
Loperamide
The metabolism of Loperamide can be decreased when combined with Metoprolol.
Lopinavir
The serum concentration of Metoprolol can be increased when it is combined with Lopinavir.
Loratadine
The serum concentration of Metoprolol can be increased when it is combined with Loratadine.
Lorcaserin
The serum concentration of Metoprolol can be increased when it is combined with Lorcaserin.
Lornoxicam
Lornoxicam may decrease the antihypertensive activities of Metoprolol.
Losartan
Metoprolol may increase the hypotensive activities of Losartan.
Lovastatin
The serum concentration of Metoprolol can be increased when it is combined with Lovastatin.
Loxoprofen
Loxoprofen may decrease the antihypertensive activities of Metoprolol.
Lucinactant
Metoprolol may increase the bradycardic activities of Lucinactant.
Luliconazole
The serum concentration of Metoprolol can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Metoprolol can be decreased when it is combined with Lumacaftor.
Lumefantrine
The serum concentration of Metoprolol can be increased when it is combined with Lumefantrine.
Macitentan
Metoprolol may increase the hypotensive activities of Macitentan.
Magnesium Salicylate
Magnesium salicylate may decrease the antihypertensive activities of Metoprolol.
Malathion
Malathion may increase the bradycardic activities of Metoprolol.
Manidipine
The serum concentration of Metoprolol can be increased when it is combined with Manidipine.
Mannitol
The risk or severity of adverse effects can be increased when Metoprolol is combined with Mannitol.
Maprotiline
The metabolism of Maprotiline can be decreased when combined with Metoprolol.
Masoprocol
Masoprocol may decrease the antihypertensive activities of Metoprolol.
Mecamylamine
Mecamylamine may increase the hypotensive activities of Metoprolol.
Meclofenamate
Meclofenamic acid may decrease the antihypertensive activities of Metoprolol.
Meclofenamic Acid
Meclofenamic acid may decrease the antihypertensive activities of Metoprolol.
Mefenamic Acid
Mefenamic acid may decrease the antihypertensive activities of Metoprolol.
Mefloquine
The serum concentration of Metoprolol can be increased when it is combined with Mefloquine.
Meloxicam
Meloxicam may decrease the antihypertensive activities of Metoprolol.
Memantine
Memantine may increase the bradycardic activities of Metoprolol.
Meperidine
The metabolism of Pethidine can be decreased when combined with Metoprolol.
Mephenytoin
The metabolism of Mephenytoin can be decreased when combined with Metoprolol.
Mephobarbital
The serum concentration of Metoprolol can be decreased when it is combined with Methylphenobarbital.
Mepirodipine
Metoprolol may increase the antihypertensive activities of Barnidipine.
Mepivacaine
The serum concentration of Mepivacaine can be increased when it is combined with Metoprolol.
Mequitazine
The metabolism of Mequitazine can be decreased when combined with Metoprolol.
Mesalamine
Mesalazine may decrease the antihypertensive activities of Metoprolol.
Mesoridazine
The metabolism of Mesoridazine can be decreased when combined with Metoprolol.
Metaproterenol
Metoprolol may decrease the bronchodilatory activities of Orciprenaline.
Methacholine
Metoprolol may increase the bronchoconstrictory activities of Methacholine.
Methadone
The serum concentration of Metoprolol can be increased when it is combined with Methadone.
Methamphetamine
The serum concentration of Metoprolol can be increased when it is combined with Methamphetamine.
Methazolamide
The serum concentration of Metoprolol can be increased when it is combined with Methazolamide.
Methimazole
The serum concentration of Metoprolol can be increased when it is combined with Methimazole.
Methohexital
The serum concentration of Metoprolol can be decreased when it is combined with Methohexital.
Methotrimeprazine
The serum concentration of Metoprolol can be increased when it is combined with Methotrimeprazine.
Methoxsalen
The serum concentration of Metoprolol can be increased when it is combined with Methoxsalen.
Methoxyflurane
The metabolism of Methoxyflurane can be decreased when combined with Metoprolol.
Methyclothiazide
The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Metoprolol.
Methyldopa
Methyldopa may increase the atrioventricular blocking (AV block) activities of Metoprolol.
METHYLDOPA ANHYDROUS
Methyldopa may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Methylene blue
Methylene blue may increase the hypotensive activities of Metoprolol.
METHYLEPHEDRINE, DL-
DL-Methylephedrine may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Methylergonovine
Metoprolol may increase the vasoconstricting activities of Methylergometrine.
Methylnaltrexone
The serum concentration of Metoprolol can be increased when it is combined with Methylnaltrexone.
Methylphenidate
The serum concentration of Metoprolol can be increased when it is combined with Methylphenidate.
Methyprylon
The metabolism of Methyprylon can be decreased when combined with Metoprolol.
Metipranolol
Metoprolol may increase the hypotensive activities of Metipranolol.
Metoclopramide
The serum concentration of Metoprolol can be increased when it is combined with Metoclopramide.
Metolazone
Metoprolol may increase the hypotensive activities of Metolazone.
Metylperon
The serum concentration of Metoprolol can be increased when it is combined with Melperone.
Metyrosine
Metoprolol may increase the hypotensive activities of Metyrosine.
Mexiletine
The metabolism of Mexiletine can be decreased when combined with Metoprolol.
Mianserin
The serum concentration of Metoprolol can be increased when it is combined with Mianserin.
Mibefradil
The serum concentration of Metoprolol can be increased when it is combined with Mibefradil.
Miconazole
The serum concentration of Metoprolol can be increased when it is combined with Miconazole.
Midodrine
The serum concentration of Metoprolol can be increased when it is combined with Midodrine.
Midostaurin
The serum concentration of Metoprolol can be increased when it is combined with Midostaurin.
Mifepristone
The serum concentration of Metoprolol can be increased when it is combined with Mifepristone.
Milnacipran
The serum concentration of Metoprolol can be increased when it is combined with Milnacipran.
Minaprine
Minaprine may increase the bradycardic activities of Metoprolol.
Minoxidil
Minoxidil may increase the hypotensive activities of Metoprolol.
Mirabegron
Mirabegron may decrease the antihypertensive activities of Metoprolol.
Mirtazapine
The serum concentration of Metoprolol can be increased when it is combined with Mirtazapine.
Moclobemide
The serum concentration of Metoprolol can be increased when it is combined with Moclobemide.
Modafinil
The metabolism of Metoprolol can be decreased when combined with Modafinil.
Moexipril
Metoprolol may increase the hypotensive activities of Moexipril.
Molsidomine
Molsidomine may increase the hypotensive activities of Metoprolol.
Moricizine
Moricizine may increase the hypotensive activities of Metoprolol.
Morphine
The metabolism of Morphine can be decreased when combined with Metoprolol.
Moxonidine
Moxonidine may increase the atrioventricular blocking (AV block) activities of Metoprolol.
MYCOPHENOLATE
Mycophenolic acid may decrease the antihypertensive activities of Metoprolol.
Mycophenolate Mofetil
Mycophenolate mofetil may decrease the antihypertensive activities of Metoprolol.
Mycophenolic Acid
Mycophenolic acid may decrease the antihypertensive activities of Metoprolol.
N-methylephedrine
DL-Methylephedrine may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Nabilone
The risk or severity of adverse effects can be increased when Nabilone is combined with Metoprolol.
Nabumetone
Nabumetone may decrease the antihypertensive activities of Metoprolol.
Nadolol
Metoprolol may increase the hypotensive activities of Nadolol.
Naftifine
Naftifine may decrease the antihypertensive activities of Metoprolol.
Naloxegol
The serum concentration of Metoprolol can be increased when it is combined with Naloxegol.
Naphazoline
Naphazoline may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Naproxen
Naproxen may decrease the antihypertensive activities of Metoprolol.
Nateglinide
The metabolism of Nateglinide can be decreased when combined with Metoprolol.
Nebivolol
The serum concentration of Nebivolol can be increased when it is combined with Metoprolol.
Nefazodone
The serum concentration of Metoprolol can be increased when it is combined with Nefazodone.
Nelfinavir
The serum concentration of Metoprolol can be increased when it is combined with Nelfinavir.
Neostigmine
Neostigmine may increase the bradycardic activities of Metoprolol.
Nepafenac
Nepafenac may decrease the antihypertensive activities of Metoprolol.
Nesiritide
The risk or severity of adverse effects can be increased when Metoprolol is combined with Nesiritide.
Netupitant
The metabolism of Netupitant can be decreased when combined with Metoprolol.
Nevirapine
The serum concentration of Metoprolol can be increased when it is combined with Nevirapine.
Niacin
The serum concentration of Metoprolol can be increased when it is combined with Niacin.
Niacinamide
The serum concentration of Metoprolol can be increased when it is combined with Nicotinamide.
Nialamide
Nialamide may increase the hypotensive activities of Metoprolol.
Nicardipine
The serum concentration of Metoprolol can be increased when it is combined with Nicardipine.
Nicergoline
Metoprolol may increase the orthostatic hypotensive activities of Nicergoline.
Nicorandil
Nicorandil may increase the hypotensive activities of Metoprolol.
Nicotine
The metabolism of Nicotine can be decreased when combined with Metoprolol.
Nicotine Polacrilex
The metabolism of Nicotine can be decreased when combined with Metoprolol.
Nifedipine
The serum concentration of Metoprolol can be increased when it is combined with Nifedipine.
Niflumic Acid
Niflumic Acid may decrease the antihypertensive activities of Metoprolol.
Nilotinib
The serum concentration of Metoprolol can be increased when it is combined with Nilotinib.
Nilvadipine
Metoprolol may increase the hypotensive activities of Nilvadipine.
Nimesulide
Nimesulide may decrease the antihypertensive activities of Metoprolol.
Nimodipine
Metoprolol may increase the hypotensive activities of Nimodipine.
Nisoldipine
Metoprolol may increase the hypotensive activities of Nisoldipine.
Nitrendipine
Metoprolol may increase the hypotensive activities of Nitrendipine.
Nitric Oxide
The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Metoprolol.
Nitrofurazone
The metabolism of Nitrofural can be decreased when combined with Metoprolol.
Nitroglycerin
The risk or severity of adverse effects can be increased when Metoprolol is combined with Nitroglycerin.
Nitroprusside
Nitroprusside may increase the hypotensive activities of Metoprolol.
Norepinephrine
Norepinephrine may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Nortriptyline
The serum concentration of Metoprolol can be increased when it is combined with Nortriptyline.
O-PHENANTHROLINE
1,10-Phenanthroline may increase the bradycardic activities of Metoprolol.
Obinutuzumab
Metoprolol may increase the hypotensive activities of Obinutuzumab.
Octreotide
Octreotide may increase the bradycardic activities of Metoprolol.
Oenothera biennis seed extract
Evening primrose oil may decrease the antihypertensive activities of Metoprolol.
Olanzapine
The serum concentration of Metoprolol can be increased when it is combined with Olanzapine.
Olmesartan
Metoprolol may increase the hypotensive activities of Olmesartan.
Olodaterol
Metoprolol may decrease the bronchodilatory activities of Olodaterol.
Olopatadine
Olopatadine may decrease the antihypertensive activities of Metoprolol.
Olsalazine
Olsalazine may decrease the antihypertensive activities of Metoprolol.
Omeprazole
The serum concentration of Metoprolol can be increased when it is combined with Omeprazole.
Ondansetron
The serum concentration of Metoprolol can be increased when it is combined with Ondansetron.
Opium
The metabolism of Opium can be decreased when combined with Metoprolol.
Ospemifene
The serum concentration of Metoprolol can be increased when it is combined with Ospemifene.
Ouabain
Metoprolol may increase the bradycardic activities of Ouabain.
Ovine Digoxin Immune Fab
Metoprolol may increase the bradycardic activities of Digoxin Immune Fab (Ovine).
Oxamniquine
The serum concentration of Metoprolol can be increased when it is combined with Oxamniquine.
Oxaprozin
Oxaprozin may decrease the antihypertensive activities of Metoprolol.
Oxprenolol
The serum concentration of Metoprolol can be increased when it is combined with Oxprenolol.
Oxybutynin
The serum concentration of Metoprolol can be increased when it is combined with Oxybutynin.
Oxycodone
The metabolism of Oxycodone can be decreased when combined with Metoprolol.
Oxymetazoline
Oxymetazoline may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Oxymetholone
The serum concentration of Metoprolol can be increased when it is combined with Oxymetholone.
Oxymorphone
The metabolism of Oxymorphone can be decreased when combined with Metoprolol.
Oxyphenbutazone
Oxyphenbutazone may decrease the antihypertensive activities of Metoprolol.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Metoprolol.
Paliperidone
Paliperidone may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Palmidrol
Palmidrol may decrease the antihypertensive activities of Metoprolol.
Palonosetron
The metabolism of Palonosetron can be decreased when combined with Metoprolol.
Panobinostat
The serum concentration of Metoprolol can be increased when it is combined with Panobinostat.
Pantoprazole
The metabolism of Metoprolol can be decreased when combined with Pantoprazole.
Papaverine
The risk or severity of adverse effects can be increased when Metoprolol is combined with Papaverine.
Parecoxib
Parecoxib may decrease the antihypertensive activities of Metoprolol.
Paregoric
The metabolism of Morphine can be decreased when combined with Metoprolol.
Pargyline
Pargyline may increase the hypotensive activities of Metoprolol.
Paroxetine
The serum concentration of Metoprolol can be increased when it is combined with Paroxetine.
Parthenolide
Parthenolide may decrease the antihypertensive activities of Metoprolol.
Pasireotide
Metoprolol may increase the bradycardic activities of Pasireotide.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Metoprolol.
Peginterferon Alfa-2b
The serum concentration of Metoprolol can be increased when it is combined with Peginterferon alfa-2b.
Penbutolol
Metoprolol may increase the hypotensive activities of Penbutolol.
Pentamidine
The serum concentration of Metoprolol can be increased when it is combined with Pentamidine.
Pentobarbital
The serum concentration of Metoprolol can be decreased when it is combined with Pentobarbital.
Pentoxifylline
Pentoxifylline may increase the hypotensive activities of Metoprolol.
Perazine
Perazine may increase the hypotensive activities of Metoprolol.
Pergolide
The serum concentration of Metoprolol can be increased when it is combined with Pergolide.
Perhexiline
The serum concentration of Metoprolol can be increased when it is combined with Perhexiline.
Periciazine
Metoprolol may increase the orthostatic hypotensive activities of Propericiazine.
Perindopril
Metoprolol may increase the hypotensive activities of Perindopril.
Perphenazine
The serum concentration of Metoprolol can be increased when it is combined with Perphenazine.
Phenacetin
The metabolism of Phenacetin can be decreased when combined with Metoprolol.
Phenelzine
Phenelzine may increase the hypotensive activities of Metoprolol.
Phenformin
The metabolism of Phenformin can be decreased when combined with Metoprolol.
Phenobarbital
The serum concentration of Metoprolol can be decreased when it is combined with Phenobarbital.
Phenoxybenzamine
Metoprolol may increase the orthostatic hypotensive activities of Phenoxybenzamine.
Phentermine
The serum concentration of Metoprolol can be increased when it is combined with Phentermine.
PHENTERMINE RESIN
The serum concentration of Metoprolol can be increased when it is combined with Phentermine.
Phentolamine
Metoprolol may increase the orthostatic hypotensive activities of Phentolamine.
Phentolamine Mesylate
Metoprolol may increase the orthostatic hypotensive activities of Phentolamine.
Phenylbutazone
Phenylbutazone may decrease the antihypertensive activities of Metoprolol.
Phenylbutyrate
The serum concentration of Metoprolol can be increased when it is combined with Phenylbutyric acid.
Phenylpropanolamine
Metoprolol may decrease the bronchodilatory activities of Phenylpropanolamine.
Phenytoin
The metabolism of Metoprolol can be increased when combined with Phenytoin.
Physostigmine
Physostigmine may increase the bradycardic activities of Metoprolol.
Pilocarpine
The risk or severity of adverse effects can be increased when Metoprolol is combined with Pilocarpine.
Pimecrolimus
Pimecrolimus may decrease the antihypertensive activities of Metoprolol.
Pimozide
The serum concentration of Metoprolol can be increased when it is combined with Pimozide.
Pinacidil
Pinacidil may increase the hypotensive activities of Metoprolol.
Pindolol
The serum concentration of Metoprolol can be increased when it is combined with Pindolol.
Pioglitazone
The serum concentration of Metoprolol can be increased when it is combined with Pioglitazone.
Pipamperone
The risk or severity of adverse effects can be increased when Pipamperone is combined with Metoprolol.
Piperazine
The metabolism of Piperazine can be decreased when combined with Metoprolol.
Pipothiazine
The serum concentration of Metoprolol can be increased when it is combined with Pipotiazine.
Pirbuterol
Metoprolol may decrease the bronchodilatory activities of Pirbuterol.
Pirfenidone
Pirfenidone may decrease the antihypertensive activities of Metoprolol.
Piroxicam
Piroxicam may decrease the antihypertensive activities of Metoprolol.
Piroxicam-Beta-Cyclodextrin
Piroxicam may decrease the antihypertensive activities of Metoprolol.
Pizotyline
Metoprolol may increase the orthostatic hypotensive activities of Pizotifen.
Polythiazide
Metoprolol may increase the hypotensive activities of Polythiazide.
Ponatinib
The metabolism of Ponatinib can be decreased when combined with Metoprolol.
Poractant alfa
Metoprolol may increase the bradycardic activities of Poractant alfa.
Pramipexole
The risk or severity of adverse effects can be increased when Pramipexole is combined with Metoprolol.
Pravastatin
The serum concentration of Metoprolol can be increased when it is combined with Pravastatin.
Praziquantel
The serum concentration of Metoprolol can be increased when it is combined with Praziquantel.
Prazosin
Metoprolol may increase the orthostatic hypotensive activities of Prazosin.
Primaquine
The serum concentration of Metoprolol can be increased when it is combined with Primaquine.
Primidone
The serum concentration of Metoprolol can be decreased when it is combined with Primidone.
Procainamide
The metabolism of Procainamide can be decreased when combined with Metoprolol.
Procaine
Procaine may increase the hypotensive activities of Metoprolol.
Procarbazine
Procarbazine may increase the hypotensive activities of Metoprolol.
Procaterol
Metoprolol may decrease the bronchodilatory activities of Procaterol.
Prochlorperazine
The metabolism of Prochlorperazine can be decreased when combined with Metoprolol.
Progesterone
The metabolism of Progesterone can be decreased when combined with Metoprolol.
Proguanil
The serum concentration of Metoprolol can be increased when it is combined with Proguanil.
Promazine
The serum concentration of Metoprolol can be increased when it is combined with Promazine.
Promethazine
The serum concentration of Metoprolol can be increased when it is combined with Promethazine.
Propafenone
The serum concentration of Metoprolol can be increased when it is combined with Propafenone.
Propiomazine
Metoprolol may increase the orthostatic hypotensive activities of Propiomazine.
Propiverine
Metoprolol may increase the orthostatic hypotensive activities of Propiverine.
Propofol
The serum concentration of Metoprolol can be increased when it is combined with Propofol.
Propoxyphene
The serum concentration of Metoprolol can be increased when it is combined with Dextropropoxyphene.
Propranolol
The serum concentration of Metoprolol can be increased when it is combined with Propranolol.
Proscillaridin
Metoprolol may increase the bradycardic activities of Proscillaridin.
Protriptyline
The metabolism of Protriptyline can be decreased when combined with Metoprolol.
Pseudoephedrine
Pseudoephedrine may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Pyridostigmine
Pyridostigmine may increase the bradycardic activities of Metoprolol.
Pyridostigmine Bromide
Pyridostigmine may increase the bradycardic activities of Metoprolol.
Pyrilamine
The serum concentration of Metoprolol can be increased when it is combined with Mepyramine.
Pyrimethamine
The serum concentration of Metoprolol can be increased when it is combined with Pyrimethamine.
Quetiapine
The serum concentration of Metoprolol can be increased when it is combined with Quetiapine.
Quetiapine fumarate
The serum concentration of Metoprolol can be increased when it is combined with Quetiapine.
Quinapril
Metoprolol may increase the hypotensive activities of Quinapril.
Quinidine
The serum concentration of Metoprolol can be increased when it is combined with Quinidine.
Quinine
The serum concentration of Metoprolol can be increased when it is combined with Quinine.
Rabeprazole
The serum concentration of Metoprolol can be increased when it is combined with Rabeprazole.
Racepinephrine
Racepinephrine may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Ramipril
Ramipril may increase the hypotensive activities of Metoprolol.
Ranitidine
The serum concentration of Metoprolol can be increased when it is combined with Ranitidine.
Ranolazine
The serum concentration of Metoprolol can be increased when it is combined with Ranolazine.
Rasagiline
Rasagiline may increase the hypotensive activities of Metoprolol.
Reboxetine
The serum concentration of Metoprolol can be increased when it is combined with Reboxetine.
Regorafenib
Regorafenib may increase the bradycardic activities of Metoprolol.
Regular Insulin, Human
Metoprolol may increase the hypoglycemic activities of Insulin Human.
Remifentanil
Remifentanil may increase the bradycardic activities of Metoprolol.
Remoxipride
The metabolism of Remoxipride can be decreased when combined with Metoprolol.
Rescinnamine
Metoprolol may increase the hypotensive activities of Rescinnamine.
Reserpine
Reserpine may increase the hypotensive activities of Metoprolol.
Resveratrol
Resveratrol may decrease the antihypertensive activities of Metoprolol.
Rifampin
The metabolism of Metoprolol can be increased when combined with Rifampicin.
Rifapentine
The serum concentration of Metoprolol can be decreased when it is combined with Rifapentine.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Metoprolol.
Rilmenidine
Rilmenidine may increase the hypotensive activities of Metoprolol.
Riociguat
Metoprolol may increase the hypotensive activities of Riociguat.
Risperidone
The serum concentration of Metoprolol can be increased when it is combined with Risperidone.
Ritodrine
Metoprolol may decrease the bronchodilatory activities of Ritodrine.
Ritonavir
The serum concentration of Metoprolol can be increased when it is combined with Ritonavir.
Rituximab
Metoprolol may increase the hypotensive activities of Rituximab.
Rivastigmine
Metoprolol may increase the bradycardic activities of Rivastigmine.
Rofecoxib
Rofecoxib may decrease the antihypertensive activities of Metoprolol.
Rolapitant
The serum concentration of Metoprolol can be increased when it is combined with Rolapitant.
Ropinirole
The serum concentration of Metoprolol can be increased when it is combined with Ropinirole.
Ropivacaine
The metabolism of Ropivacaine can be decreased when combined with Metoprolol.
Rosiglitazone
The serum concentration of Metoprolol can be increased when it is combined with Rosiglitazone.
Rotigotine
The serum concentration of Metoprolol can be increased when it is combined with Rotigotine.
Rucaparib
The serum concentration of Metoprolol can be increased when it is combined with Rucaparib.
Rutin
The serum concentration of Metoprolol can be increased when it is combined with Rutin.
Ruxolitinib
Ruxolitinib may increase the bradycardic activities of Metoprolol.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Metoprolol.
Salicylamide
Salicylamide may decrease the antihypertensive activities of Metoprolol.
Salicylic Acid
Salicylic acid may decrease the antihypertensive activities of Metoprolol.
Salmeterol
Metoprolol may decrease the bronchodilatory activities of Salmeterol.
Salsalate
Salsalate may decrease the antihypertensive activities of Metoprolol.
Saquinavir
The serum concentration of Metoprolol can be increased when it is combined with Saquinavir.
Saquinavir Mesylate
The serum concentration of Metoprolol can be increased when it is combined with Saquinavir.
Secobarbital
The serum concentration of Metoprolol can be decreased when it is combined with Secobarbital.
Selegiline
The serum concentration of Metoprolol can be increased when it is combined with Selegiline.
Selexipag
Metoprolol may increase the hypotensive activities of Selexipag.
Serratiopeptidase
Serrapeptase may decrease the antihypertensive activities of Metoprolol.
Sertindole
The metabolism of Sertindole can be decreased when combined with Metoprolol.
Sertraline
The serum concentration of Metoprolol can be increased when it is combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Metoprolol.
Sildenafil
The serum concentration of Metoprolol can be increased when it is combined with Sildenafil.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Metoprolol.
Simvastatin
The serum concentration of Metoprolol can be increased when it is combined with Simvastatin.
Sorafenib
The serum concentration of Metoprolol can be increased when it is combined with Sorafenib.
Sotalol
The risk or severity of adverse effects can be increased when Metoprolol is combined with Sotalol.
Spirapril
Metoprolol may increase the hypotensive activities of Spirapril.
Spironolactone
The risk or severity of adverse effects can be increased when Metoprolol is combined with Spironolactone.
Streptokinase
The risk or severity of adverse effects can be increased when Streptokinase is combined with Metoprolol.
Sufentanil
Sufentanil may increase the bradycardic activities of Metoprolol.
Sulconazole
The serum concentration of Metoprolol can be increased when it is combined with Sulconazole.
Sulfanilamide
The serum concentration of Metoprolol can be increased when it is combined with Sulfanilamide.
Sulfasalazine
Sulfasalazine may decrease the antihypertensive activities of Metoprolol.
Sulindac
Sulindac may decrease the antihypertensive activities of Metoprolol.
Suprofen
Suprofen may decrease the antihypertensive activities of Metoprolol.
Tacrine
Tacrine may increase the bradycardic activities of Metoprolol.
Tadalafil
Tadalafil may increase the antihypertensive activities of Metoprolol.
Talinolol
Metoprolol may increase the hypotensive activities of Talinolol.
Tamoxifen
The serum concentration of Metoprolol can be increased when it is combined with Tamoxifen.
Tamsulosin
Metoprolol may increase the orthostatic hypotensive activities of Tamsulosin.
Tapentadol
The serum concentration of Metoprolol can be increased when it is combined with Tapentadol.
Tegaserod
The serum concentration of Metoprolol can be increased when it is combined with Tegaserod.
Telithromycin
The serum concentration of Metoprolol can be increased when it is combined with Telithromycin.
Telmisartan
Metoprolol may increase the hypotensive activities of Telmisartan.
Temsirolimus
The serum concentration of Metoprolol can be increased when it is combined with Temsirolimus.
Tenoxicam
Tenoxicam may decrease the antihypertensive activities of Metoprolol.
Terazosin
Metoprolol may increase the orthostatic hypotensive activities of Terazosin.
Terbinafine
The serum concentration of Metoprolol can be increased when it is combined with Terbinafine.
Terbutaline
Metoprolol may decrease the bronchodilatory activities of Terbutaline.
Terbutaline Sulfate
Metoprolol may decrease the bronchodilatory activities of Terbutaline.
Terfenadine
The serum concentration of Metoprolol can be increased when it is combined with Terfenadine.
Teriflunomide
Teriflunomide may decrease the antihypertensive activities of Metoprolol.
Terlipressin
Metoprolol may increase the hypotensive activities of Terlipressin.
Tetrabenazine
The metabolism of Tetrabenazine can be decreased when combined with Metoprolol.
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Metoprolol.
Theodrenaline
Metoprolol may increase the hypotensive activities of Theodrenaline.
Theophylline
The metabolism of Theophylline can be decreased when combined with Metoprolol.
Theophylline anhydrous
The metabolism of Theophylline can be decreased when combined with Metoprolol.
Thiamylal
The serum concentration of Metoprolol can be decreased when it is combined with Thiamylal.
Thiethylperazine
Thiethylperazine may increase the hypotensive activities of Metoprolol.
Thiopental
The serum concentration of Metoprolol can be decreased when it is combined with Thiopental.
Thiopental Sodium
The serum concentration of Metoprolol can be decreased when it is combined with Thiopental.
Thioproperazine
Metoprolol may increase the orthostatic hypotensive activities of Thioproperazine.
Thioridazine
The serum concentration of Thioridazine can be increased when it is combined with Metoprolol.
Thiothixene
The serum concentration of Metoprolol can be increased when it is combined with Thiothixene.
Tiaprofenic Acid
Tiaprofenic acid may decrease the antihypertensive activities of Metoprolol.
Tibolone
Metoprolol may increase the hypotensive activities of Tibolone.
Ticagrelor
The serum concentration of Metoprolol can be increased when it is combined with Ticagrelor.
Ticlopidine
The serum concentration of Metoprolol can be increased when it is combined with Ticlopidine.
Timolol
The serum concentration of Metoprolol can be increased when it is combined with Timolol.
Timolol Anhydrous
The serum concentration of Metoprolol can be increased when it is combined with Timolol.
Tioconazole
The serum concentration of Metoprolol can be increased when it is combined with Tioconazole.
Tiotropium
The metabolism of Tiotropium can be decreased when combined with Metoprolol.
Tipranavir
The serum concentration of Metoprolol can be increased when it is combined with Tipranavir.
Tizanidine
Tizanidine may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Tofacitinib
Tofacitinib may increase the bradycardic activities of Metoprolol.
Tolazamide
Metoprolol may increase the hypoglycemic activities of Tolazamide.
Tolazoline
Metoprolol may increase the orthostatic hypotensive activities of Tolazoline.
Tolbutamide
Metoprolol may increase the hypoglycemic activities of Tolbutamide.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Metoprolol.
Tolfenamic Acid
Tolfenamic Acid may decrease the antihypertensive activities of Metoprolol.
Tolmetin
Tolmetin may decrease the antihypertensive activities of Metoprolol.
Toloxatone
Toloxatone may increase the hypotensive activities of Metoprolol.
Tolterodine
The metabolism of Tolterodine can be decreased when combined with Metoprolol.
Topiramate
The metabolism of Metoprolol can be decreased when combined with Topiramate.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Metoprolol.
Torsemide
Torasemide may increase the hypotensive activities of Metoprolol.
Trabectedin
The metabolism of Trabectedin can be decreased when combined with Metoprolol.
Tramadol
The serum concentration of Metoprolol can be increased when it is combined with Tramadol.
Trandolapril
Metoprolol may increase the hypotensive activities of Trandolapril.
Tranilast
Tranilast may decrease the antihypertensive activities of Metoprolol.
Tranylcypromine
The serum concentration of Metoprolol can be increased when it is combined with Tranylcypromine.
Travoprost
Metoprolol may increase the hypotensive activities of Travoprost.
Trazodone
Metoprolol may increase the orthostatic hypotensive activities of Trazodone.
Treprostinil
Metoprolol may increase the hypotensive activities of Treprostinil.
Tretinoin
The risk or severity of adverse effects can be increased when Tretinoin is combined with Metoprolol.
Triamterene
The risk or severity of adverse effects can be increased when Metoprolol is combined with Triamterene.
Tribenoside
Tribenoside may decrease the antihypertensive activities of Metoprolol.
Trichlormethiazide
Metoprolol may increase the hypotensive activities of Trichlormethiazide.
Trifluoperazine
Metoprolol may increase the orthostatic hypotensive activities of Trifluoperazine.
Triflupromazine
Triflupromazine may increase the hypotensive activities of Metoprolol.
Trimeprazine
Alimemazine may increase the hypotensive activities of Metoprolol.
Trimethaphan
Trimethaphan may increase the hypotensive activities of Metoprolol.
Trimipramine
Metoprolol may increase the orthostatic hypotensive activities of Trimipramine.
Tripelennamine
The serum concentration of Metoprolol can be increased when it is combined with Tripelennamine.
Triprolidine
The serum concentration of Metoprolol can be increased when it is combined with Triprolidine.
Trospium
The serum concentration of Metoprolol can be increased when it is combined with Trospium.
Tubocurarine
Tubocurarine may increase the bradycardic activities of Metoprolol.
Tyrothricin
Tyrothricin may increase the bradycardic activities of Metoprolol.
Umeclidinium
The metabolism of Umeclidinium can be decreased when combined with Metoprolol.
UNOPROSTONE
Metoprolol may increase the hypotensive activities of Unoprostone.
Urapidil
Metoprolol may increase the orthostatic hypotensive activities of Urapidil.
Valbenazine
The metabolism of Valbenazine can be decreased when combined with Metoprolol.
Valdecoxib
Valdecoxib may decrease the antihypertensive activities of Metoprolol.
Valsartan
Valsartan may increase the hypotensive activities of Metoprolol.
Vardenafil
Vardenafil may increase the antihypertensive activities of Metoprolol.
Varenicline
The risk or severity of adverse effects can be increased when Metoprolol is combined with Varenicline.
Vemurafenib
The serum concentration of Metoprolol can be increased when it is combined with Vemurafenib.
Venlafaxine
The serum concentration of Metoprolol can be increased when it is combined with Venlafaxine.
Verapamil
The serum concentration of Metoprolol can be increased when it is combined with Verapamil.
Vilanterol
Metoprolol may decrease the bronchodilatory activities of Vilanterol.
Vilazodone
The serum concentration of Metoprolol can be increased when it is combined with Vilazodone.
Vinblastine
The serum concentration of Metoprolol can be increased when it is combined with Vinblastine.
Vincamine
Metoprolol may increase the hypotensive activities of Vincamine.
Vincristine
The excretion of Vincristine can be decreased when combined with Metoprolol.
Vinorelbine
The serum concentration of Metoprolol can be increased when it is combined with Vinorelbine.
Vinpocetine
Metoprolol may increase the hypotensive activities of Vinpocetine.
Voriconazole
The metabolism of Metoprolol can be decreased when combined with Voriconazole.
Vortioxetine
The metabolism of Vortioxetine can be decreased when combined with Metoprolol.
Xylazine
Xylazine may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Xylometazoline
Xylometazoline may increase the atrioventricular blocking (AV block) activities of Metoprolol.
Yohimbine
The serum concentration of Metoprolol can be increased when it is combined with Yohimbine.
Zafirlukast
The serum concentration of Metoprolol can be increased when it is combined with Zafirlukast.
Zalcitabine
The metabolism of Zalcitabine can be decreased when combined with Metoprolol.
Zileuton
Zileuton may decrease the antihypertensive activities of Metoprolol.
Ziprasidone
The serum concentration of Metoprolol can be increased when it is combined with Ziprasidone.
Zofenopril
Metoprolol may increase the hypotensive activities of Zofenopril.
Zolpidem
The metabolism of Zolpidem can be decreased when combined with Metoprolol.
Zomepirac
Zomepirac may decrease the antihypertensive activities of Metoprolol.
Zuclopenthixol
Metoprolol may increase the orthostatic hypotensive activities of Zuclopenthixol.
